Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07449416 · ClinicalTrials.gov registry record · NA
Ceribell Delirium Monitor Outcomes Pilot Study
A NA study, sponsored by Ceribell.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07449416 is a NA study that has not yet begun recruiting, run by Ceribell. The registered enrollment target is 100 participants.
The verdict
NCT07449416, a NA study, has not yet begun recruiting, sponsored by Ceribell.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.
Interventions
- DEVICE Ceribell Delirium Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-03-15 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07449416
The ClinicalTrials.gov registry entry for NCT07449416 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ceribell, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceribell Delirium Monitoring System is the first listed.
NCT07449416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07449416 about?
NCT07449416 is a clinical study titled "Ceribell Delirium Monitor Outcomes Pilot Study". This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.
What is the current status of trial NCT07449416?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-03-15. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07449416?
The interventions under investigation include: Ceribell Delirium Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT07449416?
This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.